These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15535984)

  • 1. An evaluation of the P450 inhibition and induction potential of daptomycin in primary human hepatocytes.
    Oleson FB; Berman CL; Li AP
    Chem Biol Interact; 2004 Nov; 150(2):137-47. PubMed ID: 15535984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of liposomal curcumin cytochrome p450 metabolism.
    Mach CM; Chen JH; Mosley SA; Kurzrock R; Smith JA
    Anticancer Res; 2010 Mar; 30(3):811-4. PubMed ID: 20393001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
    Westerink WM; Schoonen WG
    Toxicol In Vitro; 2007 Dec; 21(8):1581-91. PubMed ID: 17637504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of a dry extract from milk thistle (Silybum marianum) for interference with human liver cytochrome-P450 activities.
    Doehmer J; Weiss G; McGregor GP; Appel K
    Toxicol In Vitro; 2011 Feb; 25(1):21-7. PubMed ID: 20828605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition and induction of human cytochrome P450 enzymes in vitro by capsaicin.
    Babbar S; Chanda S; Bley K
    Xenobiotica; 2010 Dec; 40(12):807-16. PubMed ID: 20863199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro studies investigating the interactions between degarelix, a decapeptide gonadotropin-releasing hormone blocker, and cytochrome P450.
    Sonesson A; Rasmussen BB
    Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):195-202. PubMed ID: 21496210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of active hexose correlated compound hepatic metabolism and potential for drug interactions with chemotherapy agents.
    Mach CM; Fugii H; Wakame K; Smith J
    J Soc Integr Oncol; 2008; 6(3):105-9. PubMed ID: 19087767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and induction potential of cytochromes P450 in human cryopreserved hepatocytes.
    Roymans D; Annaert P; Van Houdt J; Weygers A; Noukens J; Sensenhauser C; Silva J; Van Looveren C; Hendrickx J; Mannens G; Meuldermans W
    Drug Metab Dispos; 2005 Jul; 33(7):1004-16. PubMed ID: 15802389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood monocyte-derived neohepatocytes as in vitro test system for drug metabolism.
    Ehnert S; Nussler AK; Lehmann A; Dooley S
    Drug Metab Dispos; 2008 Sep; 36(9):1922-9. PubMed ID: 18559486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism Comparative Cytotoxicity Assay (MCCA) and Cytotoxic Metabolic Pathway Identification Assay (CMPIA) with cryopreserved human hepatocytes for the evaluation of metabolism-based cytotoxicity in vitro: proof-of-concept study with aflatoxin B1.
    Li AP
    Chem Biol Interact; 2009 Apr; 179(1):4-8. PubMed ID: 18950609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lenalidomide: in vitro evaluation of the metabolism and assessment of cytochrome P450 inhibition and induction.
    Kumar G; Lau H; Laskin O
    Cancer Chemother Pharmacol; 2009 May; 63(6):1171-5. PubMed ID: 19030860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar.
    Zhang D; Wang L; Chandrasena G; Ma L; Zhu M; Zhang H; Davis CD; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):139-49. PubMed ID: 17062778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytochrome p450 induction and inhibition potential of clevidipine and its primary metabolite h152/81.
    Zhang JG; Dehal SS; Ho T; Johnson J; Chandler C; Blanchard AP; Clark RJ; Crespi CL; Stresser DM; Wong J
    Drug Metab Dispos; 2006 May; 34(5):734-7. PubMed ID: 16501008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects on cytochrome p450 enzymes of pentamidine and its amidoxime pro-drug.
    Bürenheide A; Kunze T; Clement B
    Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):61-5. PubMed ID: 18346045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of a substrate cassette strategy to improve the capacity and throughput of cytochrome P450 induction studies in human hepatocytes.
    Mohutsky MA; Petullo DM; Wrighton SA
    Drug Metab Dispos; 2005 Jul; 33(7):920-3. PubMed ID: 15802386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of colchicine and its derivatives on the expression of selected isoforms of cytochrome P450 in primary cultures of human hepatocytes.
    Dvorák Z; Ulrichová J; Modrianský M; Maurel P
    Acta Univ Palacki Olomuc Fac Med; 2000; 143():47-50. PubMed ID: 11144118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic.
    Foster BC; Foster MS; Vandenhoek S; Krantis A; Budzinski JW; Arnason JT; Gallicano KD; Choudri S
    J Pharm Pharm Sci; 2001; 4(2):176-84. PubMed ID: 11466175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes.
    McGinnity DF; Berry AJ; Kenny JR; Grime K; Riley RJ
    Drug Metab Dispos; 2006 Aug; 34(8):1291-300. PubMed ID: 16679385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of extracts from mistletoe (Viscum album) for herb-drug interaction by inhibition and induction of cytochrome P450 activities.
    Doehmer J; Eisenbraun J
    Phytother Res; 2012 Jan; 26(1):11-7. PubMed ID: 21538623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro evaluation of the victim and perpetrator potential of the anticancer agent laromustine (VNP40101M), based on reaction phenotyping and inhibition and induction of cytochrome P450 enzymes.
    Nassar AE; King I; Paris BL; Haupt L; Ndikum-Moffor F; Campbell R; Usuki E; Skibbe J; Brobst D; Ogilvie BW; Parkinson A
    Drug Metab Dispos; 2009 Sep; 37(9):1922-30. PubMed ID: 19520774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.